vs
Side-by-side financial comparison of Life360, Inc. (LIF) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
Life360, Inc. is the larger business by last-quarter revenue ($146.0M vs $123.8M, roughly 1.2× NATURES SUNSHINE PRODUCTS INC). Life360, Inc. runs the higher net margin — 88.8% vs 3.3%, a 85.5% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 4.7%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $7.6M). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 5.6%).
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
LIF vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $146.0M | $123.8M |
| Net Profit | $129.7M | $4.1M |
| Gross Margin | 75.1% | 72.5% |
| Operating Margin | 6.1% | 4.3% |
| Net Margin | 88.8% | 3.3% |
| Revenue YoY | 26.4% | 4.7% |
| Net Profit YoY | 1425.9% | 1379.4% |
| EPS (diluted) | $1.53 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $146.0M | $123.8M | ||
| Q3 25 | $124.5M | $128.3M | ||
| Q2 25 | $115.4M | $114.8M | ||
| Q1 25 | $103.6M | $113.2M | ||
| Q4 24 | $115.5M | $118.2M | ||
| Q3 24 | $92.9M | $114.6M | ||
| Q2 24 | $84.9M | $110.6M | ||
| Q1 24 | $78.2M | $111.0M |
| Q4 25 | $129.7M | $4.1M | ||
| Q3 25 | $9.8M | $5.3M | ||
| Q2 25 | $7.0M | $5.3M | ||
| Q1 25 | $4.4M | $4.7M | ||
| Q4 24 | $8.5M | $-321.0K | ||
| Q3 24 | $7.7M | $4.3M | ||
| Q2 24 | $-11.0M | $1.3M | ||
| Q1 24 | $-9.8M | $2.3M |
| Q4 25 | 75.1% | 72.5% | ||
| Q3 25 | 78.0% | 73.3% | ||
| Q2 25 | 78.4% | 71.7% | ||
| Q1 25 | 80.6% | 72.1% | ||
| Q4 24 | 74.0% | 72.0% | ||
| Q3 24 | 75.4% | 71.3% | ||
| Q2 24 | 75.0% | 71.4% | ||
| Q1 24 | 76.7% | 71.2% |
| Q4 25 | 6.1% | 4.3% | ||
| Q3 25 | 4.6% | 7.0% | ||
| Q2 25 | 1.7% | 3.7% | ||
| Q1 25 | 2.1% | 5.4% | ||
| Q4 24 | 4.9% | 3.8% | ||
| Q3 24 | -5.3% | 4.6% | ||
| Q2 24 | -2.8% | 5.1% | ||
| Q1 24 | -8.2% | 4.2% |
| Q4 25 | 88.8% | 3.3% | ||
| Q3 25 | 7.9% | 4.2% | ||
| Q2 25 | 6.1% | 4.6% | ||
| Q1 25 | 4.2% | 4.2% | ||
| Q4 24 | 7.4% | -0.3% | ||
| Q3 24 | 8.3% | 3.8% | ||
| Q2 24 | -12.9% | 1.2% | ||
| Q1 24 | -12.5% | 2.1% |
| Q4 25 | $1.53 | $0.23 | ||
| Q3 25 | $0.11 | $0.30 | ||
| Q2 25 | $0.08 | $0.28 | ||
| Q1 25 | $0.05 | $0.25 | ||
| Q4 24 | $0.14 | $-0.02 | ||
| Q3 24 | $0.09 | $0.23 | ||
| Q2 24 | $-0.15 | $0.07 | ||
| Q1 24 | $-0.14 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $494.3M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $548.2M | $161.6M |
| Total Assets | $959.7M | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $494.3M | $93.9M | ||
| Q3 25 | $455.7M | $95.6M | ||
| Q2 25 | $432.7M | $81.3M | ||
| Q1 25 | $168.9M | $86.5M | ||
| Q4 24 | $159.2M | $84.7M | ||
| Q3 24 | $159.0M | $78.7M | ||
| Q2 24 | $160.8M | $68.7M | ||
| Q1 24 | $73.4M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $5.2M | $2.1M |
| Q4 25 | $548.2M | $161.6M | ||
| Q3 25 | $391.4M | $166.7M | ||
| Q2 25 | $366.7M | $163.7M | ||
| Q1 25 | $376.3M | $167.1M | ||
| Q4 24 | $358.5M | $161.0M | ||
| Q3 24 | $339.7M | $162.6M | ||
| Q2 24 | $326.7M | $156.4M | ||
| Q1 24 | $239.8M | $159.7M |
| Q4 25 | $959.7M | $261.1M | ||
| Q3 25 | $787.5M | $264.8M | ||
| Q2 25 | $753.6M | $254.9M | ||
| Q1 25 | $455.4M | $252.7M | ||
| Q4 24 | $441.6M | $240.9M | ||
| Q3 24 | $427.4M | $245.3M | ||
| Q2 24 | $405.9M | $235.8M | ||
| Q1 24 | $318.8M | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.02× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $36.8M | $9.9M |
| Free Cash FlowOCF − Capex | $36.6M | $7.6M |
| FCF MarginFCF / Revenue | 25.1% | 6.1% |
| Capex IntensityCapex / Revenue | 0.2% | 1.9% |
| Cash ConversionOCF / Net Profit | 0.28× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $86.8M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $9.9M | ||
| Q3 25 | $26.4M | $18.5M | ||
| Q2 25 | $13.3M | $4.3M | ||
| Q1 25 | $12.1M | $2.6M | ||
| Q4 24 | $12.3M | $12.2M | ||
| Q3 24 | $6.3M | $9.6M | ||
| Q2 24 | $3.3M | $1.3M | ||
| Q1 24 | $10.7M | $2.2M |
| Q4 25 | $36.6M | $7.6M | ||
| Q3 25 | $25.6M | $16.8M | ||
| Q2 25 | $12.7M | $3.0M | ||
| Q1 25 | $11.9M | $1.5M | ||
| Q4 24 | $11.2M | $10.0M | ||
| Q3 24 | $6.3M | $7.9M | ||
| Q2 24 | $3.2M | $-2.0M | ||
| Q1 24 | — | $-1.5M |
| Q4 25 | 25.1% | 6.1% | ||
| Q3 25 | 20.6% | 13.1% | ||
| Q2 25 | 11.0% | 2.6% | ||
| Q1 25 | 11.5% | 1.3% | ||
| Q4 24 | 9.7% | 8.5% | ||
| Q3 24 | 6.8% | 6.9% | ||
| Q2 24 | 3.8% | -1.9% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | 0.2% | 1.9% | ||
| Q3 25 | 0.6% | 1.3% | ||
| Q2 25 | 0.6% | 1.2% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 1.0% | 1.9% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | 0.0% | 3.3% |
| Q4 25 | 0.28× | 2.41× | ||
| Q3 25 | 2.70× | 3.46× | ||
| Q2 25 | 1.90× | 0.81× | ||
| Q1 25 | 2.75× | 0.55× | ||
| Q4 24 | 1.45× | — | ||
| Q3 24 | 0.83× | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LIF
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
